Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Donald P. LehrChief Legal Officer | PrecigenPGEN | Open-market sale | 05/28 | 06/01 | 29,131 sh | $4.36 | $127,011.16 | −3.7% |
Helen SabzevariPresident and CEO | PrecigenPGEN | Open-market sale | 05/28 | 06/01 | 119,250 sh | $4.36 | $519,930 | −3.1% |
PrecigenPGEN | Open-market sale | 05/28 | 06/01 | 41,884 sh | $4.36 | $182,614.24 | −7.0% | |
PrecigenPGEN | Open-market sale | 05/28 | 06/01 | 42,703 sh | $4.36 | $186,185.08 | −7.9% | |
Phil TennantChief Commercial Officer | PrecigenPGEN | Open-market sale | 05/28 | 06/01 | 30,272 sh | $4.36 | $131,985.92 | −17.8% |
PrecigenPGEN | Open-market sale | 03/30 | 03/31 | 4,772,781 sh11 trades | $3.30avg. | $15,750,177.3 | −28.0% | |
PrecigenPGEN | Open-market sale | 25/12/22 | 25/12/22 | 1,900,036 sh11 trades | $4.18avg. | $7,942,150.48 | −29.2% | |
Jeffrey B. KindlerDirector | PrecigenPGEN | Open-market sale | 25/12/12 | 25/12/16 | 235,467 sh | $3.63 | $854,745.21 | −68.0% |
PrecigenPGEN | Open-market sale | 25/11/19–25/11/21 | 25/11/21 | 2,966,293 sh3 trades | $4.14avg. | $12,291,748.11 | −34.8% | |
PrecigenPGEN | Open-market sale | 25/09/29–25/09/30 | 25/10/01 | 174,360 sh2 trades | $3.47avg. | $604,191.86 | −33.5% | |
Randal J. KirkDirector | PrecigenPGEN | Open-market sale | 25/09/30 | 25/09/30 | 1,809,667 sh | $3.41 | $6,170,964.47 | −11.0% |
Phil TennantChief Commercial Officer | PrecigenPGEN | Open-market buy | 25/09/29 | 25/09/30 | 6,000 sh | $3.58 | $21,480 | +10.2% |
PrecigenPGEN | Open-market buy | 25/09/26 | 25/09/30 | 2,000 sh | $3.40 | $6,800 | +0.5% | |
CFO | PrecigenPGEN | Open-market buy | 25/09/25–25/09/26 | 25/09/26 | 11,216 sh2 trades | $3.57avg. | $40,015.52 | +2.5% |
PrecigenPGEN | Open-market sale | 25/09/18–25/09/19 | 25/09/19 | 5,000,252 sh2 trades | $3.73avg. | $18,653,532.16 | −37.0% | |
Nancy H. AgeeDirector | PrecigenPGEN | Open-market buy | 25/09/04 | 25/09/05 | 15,000 sh | $4.60 | $69,000 | +7.4% |
PrecigenPGEN | Open-market buy | 25/08/19–25/08/28 | 25/08/29 | 26,005 sh2 trades | $3.79avg. | $98,651.25 | +14.7% | |
Randal J. KirkDirector | PrecigenPGEN | Open-market buy | 24/08/09 | 24/08/13 | 23,529,411 sh | $0.85 | $19,999,999.35 | +57.4% |
Jeffrey Thomas PerezSVP, IP Affairs | PrecigenPGEN | Open-market buy | 24/08/09 | 24/08/13 | 58,823 sh | $0.85 | $49,999.55 | +8.6% |
Randal J. KirkDirector | PrecigenPGEN | Open-market buy | 23/12/28 | 23/12/29 | 96,686 sh | $1.41 | $136,327.26 | +9.7% |
